Coverage
-
September 16, 2022
A Brooklyn federal judge has given an initial nod to the proposed $11.5 million settlement of investors' claims that Vanda Pharmaceuticals Inc. hid from the public that it was illegally marketing its drugs for off-label use.
2 other articles on this case.
View all »